Subscribe
Strategy
5 min read

Purina's $644M Italy Plant Bets the Premium Fight on Wet Food, Not Fresh

Nestlé Purina confirmed a CHF 520 million ($644 million) superpremium wet pet food factory in Mantova, Italy, with production starting in 2029. The category leader is betting Europe's premium migration lands on shelf-stable wet rather than refrigerated fresh — and the three-year capacity gap before the plant opens is the operator opportunity.

Written by
The Underbite
Published on
July 21, 2026
Purina's $644M Italy Plant Bets the Premium Fight on Wet Food, Not Fresh

Nestlé Purina will spend CHF 520 million (about $644 million) on a new factory in Mantova, Italy, dedicated to superpremium wet food for cats and dogs, with production starting in 2029. It is the clearest signal yet of where the category's largest player thinks premiumization actually lands: in the pouch and the can, not the refrigerator case its rivals have been building toward.

Nestlé confirms a CHF 520 million wet-food hub in Mantova, bigger and later than the 2024 plan

The announcement, published July 20 on Nestlé's corporate newsroom, confirms and expands a project two years in the works. When Italy's industry ministry first described the Mantova plan in April 2024, per Reuters reporting at the time, the figure was €472 million (then about $507 million), with completion targeted for 2027 and roughly 300 jobs across a 180,000-square-meter site in the Valdaro industrial area. The confirmed project is larger, at CHF 520 million, and later: production is now expected to begin in 2029.

The plant becomes Purina's 15th production site in Europe and doubles as an integrated logistics platform serving multiple Nestlé brands, positioned in what Nestlé Italy president and CEO Marco Travaglia called "the heart of European transport corridors." Italy is contributing €60 million in state aid, approved by the European Commission last year, per Swissinfo.

The stated demand case: Europe now has around 111 million cats and 91 million dogs, and high-quality wet food, particularly for cats, is growing at roughly 8% a year, per the release. "Superpremium wet pet food is particularly attractive right now," said Rafael López, CEO of Nestlé Purina PetCare Europe. Petcare accounts for 29% of Nestlé's European turnover and is one of four strategic growth pillars under CEO Philipp Navratil.

The category leader is pouring capex into shelf-stable superpremium while rivals experiment with the fridge

The most interesting thing about this investment is the format it does not touch. The premium end of pet food has spent 2026 crowding into refrigerated fresh: Royal Canin launched its first fresh therapeutic diets in July, Hill's shipped its first refrigerated line, Science Diet rolls, into pet specialty this summer, and Freshpet's entire model is the branded fridge. Purina, which sells more pet food than any of them, just committed nearly two-thirds of a billion dollars to the proposition that superpremium's center of gravity stays shelf-stable.

That is not a defensive read. Wet food delivers most of what fresh promises the consumer — palatability, texture variety, high moisture, a "real food" sensory experience — at superpremium price points, without cold-chain logistics, retailer fridge negotiations, or short shelf lives. If the premium migration can be served in a pouch at ambient temperature, the economics favor whoever holds the most capacity, and Purina is building it. Mantova follows the same playbook as the CHF 370 million wet food factory Purina inaugurated in Brazil in March, which nearly doubled its wet capacity in that market.

The second read is about who else is buying European wet capacity. Days before Purina's announcement surfaced, United Petfood, the Ghent-based co-manufacturer with 29 plants, took a 50% stake in SmartPetPro, a German premium wet producer. Branded capex and private-label consolidation are converging on the same conclusion: European premium wet is supply-constrained, and the capacity that exists is being locked up. For operators who co-manufacture wet SKUs, tightening capacity means longer lead times and thinner negotiating leverage. Worth stress-testing supply agreements now, not in 2028.

Cats are the quiet engine here. Europe has 20 million more cats than dogs, the 8% growth figure Nestlé cites is led by wet cat food, and wet formats skew feline. A superpremium wet bet is, in large part, a cat premiumization bet.

A 2029 start date leaves a three-year capacity window, and Nestlé's next report will show how hard it leans in

The gap between demand signal and capacity arrival is the operational story. Purina's plant does not produce until 2029; the 8% growth is happening now. That leaves roughly three years in which European superpremium wet demand outruns branded capacity, a window for challenger brands, importers, and co-manufacturers to take share before the category's biggest new plant comes online. Note the slip, too: the 2024 plan targeted 2027 completion. Big-plant timelines in this category move.

Watch three things. First, whether Mars answers with European wet capacity of its own or keeps pushing Royal Canin toward fresh; the two biggest players in pet food are now visibly split on format. Second, the co-manufacturing consolidation: whether United Petfood's SmartPetPro deal closes and is followed by more premium wet acquisitions. Third, Nestlé's next results: petcare is 29% of European turnover and a stated growth pillar, so wet-food commentary in the company's half-year reporting will show whether Mantova is the start of a broader capacity cycle rather than a one-off. Freshpet's August 5 earnings offer the counter-read from the fresh side of the format bet.

Source: Nestlé Purina PetCare announcement via Nestlé newsroom

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
An Angel Network of Vets Backs a Platform That Pays the Clinic Before the Client Leaves
Funding & M&A
4 min read

An Angel Network of Vets Backs a Platform That Pays the Clinic Before the Client Leaves

PawPay has become the newest portfolio company of the Veterinary Angel Network for Entrepreneurs on undisclosed terms. Acting as an authorized collection agent, the platform verifies coverage at checkout, collects only the owner's deductible and coinsurance, pays the clinic in full within minutes, and manages reimbursement with the carrier. It is free for practices to join and targets the direct-pay experience Trupanion has largely owned.

Read article
Read article
CVS's 9,000-Store Pet Meds Launch Comes for the Vet Pharmacy Margin
Strategy
5 min read

CVS's 9,000-Store Pet Meds Launch Comes for the Vet Pharmacy Margin

CVS Health switched on prescription pet medication dispensing at roughly 9,000 pharmacies nationwide, with app-based pet profiles and e-prescribing due within months. With human-generic pricing behind it, the highest-margin line in the vet clinic P&L just got a national competitor.

Read article
Read article
Virbac Grows Companion Animal 10% in the Same Half That Flattened Boehringer
Earnings
5 min read

Virbac Grows Companion Animal 10% in the Same Half That Flattened Boehringer

Virbac grew H1 2026 revenue 7.4% to €768 million, with companion animal up 10% and North America up 10.1%, and now targets the top of its guidance range. In the same half, Boehringer's animal health sales went nearly flat. The divergence shows chronic-care mix, not market beta, is deciding who grows through the vet-traffic slump.

Read article
View all articles